999765843	999765843	CD	B-NP	O
|	|	NNP	I-NP	O
EG	EG	NNP	I-NP	O
|	|	VBD	B-VP	O
05907477	05907477	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4144301	4144301	CD	B-NP	O
|	|	CC	I-NP	O
8/14/2002	8/14/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CELLULITIS	CELLULITIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/14/2002	8/14/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/6/2002	10/6/2002	CD	B-NP	O
SERVICE	SERVICE	NN	I-NP	O
:	:	:	O	O
General	General	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Service	Service	NNP	I-NP	O
Au	Au	NNP	I-NP	O
Alldown	Alldown	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
Vascular	Vascular	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
known	know	VBN	B-VP	O
vascular	vascular	JJ	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
incontinence	incontinence	NN	B-NP	O
,	,	,	O	O
recurrent	recurrent	JJ	B-NP	O
UTIs	UTI	NNS	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
89-year-old	89-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
dependent	dependent	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
ejection	ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
28	28	CD	B-NP	O
%	%	NN	I-NP	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
fem-peroneal	fem-peroneal	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
on-going	on-going	JJ	B-NP	O
left	left	JJ	I-NP	O
toe	toe	NN	I-NP	O
pain	pain	NN	I-NP	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
left	left	JJ	B-NP	O
toe	toe	NN	I-NP	O
vascular	vascular	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
and	and	CC	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
refractory	refractory	JJ	B-ADJP	O
to	to	TO	B-PP	O
treatment	treatment	NN	B-NP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reported	report	VBD	B-VP	O
having	have	VBG	I-VP	O
her	her	PRP$	B-NP	O
podiatrist	podiatrist	NN	I-NP	O
clip	clip	VB	B-VP	O
her	her	PRP$	B-NP	O
nails	nail	NNS	I-NP	O
about	about	IN	B-PP	O
two	two	CD	B-NP	O
months	month	NNS	I-NP	O
ago	ago	IN	B-ADVP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
when	when	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
foot	foot	NN	I-NP	O
started	start	VBD	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
fever	fever	NN	I-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
cough	cough	NN	B-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
vomiting	vomiting	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
home	home	NN	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
ambulate	ambulate	VB	I-VP	O
,	,	,	O	O
but	but	CC	O	O
had	have	VBD	B-VP	O
significant	significant	JJ	B-NP	O
pain	pain	NN	I-NP	O
localizing	localize	VBG	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
foot	foot	NN	I-NP	O
and	and	CC	I-NP	O
toe	toe	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
recently	recently	RB	I-VP	O
admitted	admit	VBN	I-VP	O
here	here	RB	B-ADVP	O
on	on	IN	B-PP	O
July	July	NNP	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
complaint	complaint	NN	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
and	and	CC	I-NP	O
clindamycin	clindamycin	NN	I-NP	O
for	for	IN	B-PP	O
five	five	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
then	then	RB	O	O
went	go	VBD	B-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
ten	ten	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
dicloxacillin	dicloxacillin	NN	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Keflex	Keflex	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
comes	come	VBZ	B-VP	O
back	back	RB	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
April	April	NNP	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
infection	infection	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
foot	foot	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
and	and	CC	O	O
stable	stable	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

Exam	Exam	NNP	B-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
soft	soft	JJ	I-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
base	base	NN	I-NP	O
,	,	,	O	O
non-palpable	non-palpable	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
.	.	.	O	O

Left	Leave	VBN	B-NP	O
foot	foot	NN	I-NP	O
was	be	VBD	B-VP	O
cool	cool	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
swelling	swell	VBG	I-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
dorsum	dorsum	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
foot	foot	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ankle	ankle	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
superficial	superficial	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
along	along	IN	B-PP	O
the	the	DT	B-NP	O
medial	medial	JJ	I-NP	O
aspect	aspect	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nail	nail	NN	I-NP	O
bed	bed	NN	I-NP	O
without	without	IN	B-PP	O
purulence	purulence	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
normal	normal	JJ	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
and	and	CC	O	O
negative	negative	JJ	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
taken	take	VBN	B-VP	O
here	here	RB	B-ADVP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Status	Status	NNP	B-NP	O
post	post	IN	B-PP	O
CVA	CVA	NNP	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
carotid	carotid	NN	I-NP	O
endarterectomy	endarterectomy	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
fem-peroneal	fem-peroneal	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
in	in	IN	B-PP	O
1997	1997	CD	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
inflammatory	inflammatory	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
28	28	CD	B-NP	O
to	to	TO	I-NP	O
30	30	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
,	,	,	O	O
recurrent	recurrent	JJ	B-NP	O
UTIs	UTI	NNS	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
non-Q	non-Q	JJ	B-NP	O
wave	wave	NN	I-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
cataracts	cataract	NNS	B-NP	O
,	,	,	O	O
stress	stress	NN	B-NP	O
incontinence	incontinence	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Include	Include	NNP	B-NP	O
lactulose	lactulose	NN	I-NP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
,	,	,	O	O
Metamucil	Metamucil	NNP	B-NP	O
,	,	,	O	O
Paxil	Paxil	NNP	B-NP	O
,	,	,	O	O
Cozaar	Cozaar	NNP	B-NP	O
,	,	,	O	O
Neurontin	Neurontin	NNP	B-NP	O
,	,	,	O	O
Metformin	Metformin	NNP	B-NP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Allergies	Allergy	NNS	B-NP	O
to	to	TO	B-PP	O
sulfa	sulfa	NN	B-NP	O
,	,	,	O	O
Mavik	Mavik	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
verapamil	verapamil	NN	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Noncontributory	Noncontributory	JJ	B-ADJP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	B-protein
family	family	NN	I-NP	I-protein
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
the	the	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
illness	illness	NN	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
VITAL	VITAL	JJ	B-NP	O
SIGNS	SIGNS	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
98.3	98.3	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
100	100	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
184/100	184/100	CD	I-NP	O
,	,	,	O	O
breathing	breathing	NN	B-NP	O
20	20	CD	I-NP	O
and	and	CC	O	O
satting	satte	VBG	B-VP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

GENERAL	GENERAL	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
obese	obese	NN	B-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Clear	Clear	NNP	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
adenopathy	adenopathy	NN	I-NP	O
.	.	.	O	O

Oropharynx	Oropharynx	NN	B-NP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	O
:	:	:	O	O
Jugular	Jugular	JJ	B-NP	O
venous	venous	JJ	I-NP	O
distention	distention	NN	I-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
eight	eight	CD	I-NP	O
centimeters	centimeter	NNS	I-NP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
.	.	.	O	O

PULMONARY	PULMONARY	NN	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-NP	O
,	,	,	I-NP	O
non-tender	non-tender	JJ	I-NP	O
,	,	,	I-NP	O
non-distended	non-distended	JJ	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
organomegaly	organomegaly	NN	I-NP	O
.	.	.	O	O

Obese	Obese	UH	B-INTJ	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
Left	Left	JJ	B-NP	O
foot	foot	NN	I-NP	O
swollen	swell	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ankle	ankle	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
dorsum	dorsum	NN	I-NP	O
,	,	,	O	O
erythema	erythema	NN	B-NP	O
.	.	.	O	O

Superficial	Superficial	JJ	B-NP	O
ulceration	ulceration	NN	I-NP	O
along	along	IN	B-PP	O
the	the	DT	B-NP	O
lateral	lateral	JJ	I-NP	O
first	first	JJ	I-NP	O
toenail	toenail	NN	I-NP	O
bed	bed	NN	I-NP	O
without	without	IN	B-PP	O
purulence	purulence	NN	B-NP	O
.	.	.	O	O

Left	Leave	VBN	B-NP	O
foot	foot	NN	I-NP	O
was	be	VBD	B-VP	O
cool	cool	JJ	B-ADJP	O
.	.	.	O	O

Non-palpable	Non-palpable	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
in	in	IN	B-PP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
.	.	.	O	O

NEUROLOGIC	NEUROLOGIC	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Able	Able	NN	B-NP	O
to	to	TO	B-VP	O
ambulate	ambulate	VB	I-VP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
difficulty	difficulty	NN	I-NP	O
and	and	CC	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
superimposed	superimpose	VBN	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
poor	poor	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
perfusion	perfusion	NN	I-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
peripheral	peripheral	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
MRI	MRI	NN	I-NP	B-protein
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
concerning	concern	VBG	I-VP	O
for	for	IN	B-PP	O
early	early	JJ	B-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
and	and	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
concern	concern	NN	B-NP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
bypass	bypass	NN	I-NP	O
graft	graft	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
leg	leg	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
patent	patent	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
angiography	angiography	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
leg	leg	NN	I-NP	O
vessels	vessel	NNS	I-NP	O
and	and	CC	O	O
proceeded	proceed	VBD	B-VP	O
to	to	TO	I-VP	O
get	get	VB	I-VP	O
stenting	stenting	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
common	common	JJ	I-NP	O
iliac	iliac	JJ	I-NP	O
and	and	CC	I-NP	O
external	external	JJ	I-NP	O
iliac	iliac	JJ	I-NP	O
vessels	vessel	NNS	I-NP	O
without	without	IN	B-PP	O
complication	complication	NN	B-NP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
LFTs	LFT	NNS	B-NP	B-protein
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
attributed	attribute	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
three	three	CD	I-NP	O
gram	gram	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Unasyn	Unasyn	NNP	B-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
received	receive	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Unasyn	Unasyn	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
IV	IV	CD	B-NP	O
clindamycin	clindamycin	NN	I-NP	O
and	and	CC	I-NP	O
levo	levo	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
calcified	calcify	VBN	I-NP	O
gallbladder	gallbladder	NN	I-NP	O
wall	wall	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
obstruction	obstruction	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
LFTs	LFT	NNS	I-NP	B-protein
then	then	RB	B-ADVP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
normalize	normalize	VB	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
status	status	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
for	for	IN	B-PP	O
30	30	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
stenting	stenting	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
iliac	iliac	JJ	I-NP	O
vessels	vessel	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
PICC	PICC	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
for	for	IN	B-PP	O
on-going	on-going	JJ	B-NP	O
IV	IV	CD	I-NP	O
antibiotics	antibiotic	NNS	I-NP	O
PLAN	PLAN	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
plan	plan	NN	I-NP	O
is	be	VBZ	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Plavix	Plavix	NN	B-NP	O
times	time	NNS	I-NP	O
30	30	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
75	75	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

IV	IV	CD	B-NP	O
clindamycin	clindamycin	NN	I-NP	O
and	and	CC	I-NP	O
p.o.	p.o.	NN	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
for	for	IN	B-PP	O
another	another	DT	B-NP	O
ten	ten	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	B-VP	O
switch	switch	VB	I-VP	O
to	to	TO	I-VP	O
p.o.	p.o.	VB	I-VP	O
Flagyl	Flagyl	NN	B-NP	O
and	and	CC	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
four	four	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Renato	Renato	NNP	I-NP	O
Hypolite	Hypolite	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Vascular	Vascular	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
as	as	IN	B-SBAR	O
planned	plan	VBN	B-VP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Please	Please	VB	B-VP	O
continue	continue	VB	I-VP	O
checking	check	VBG	I-VP	O
fingerstick	fingerstick	NN	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
and	and	CC	I-NP	O
h.s.	h.s.	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
:	:	:	O	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
bacitracin	bacitracin	NN	B-NP	O
,	,	,	O	O
Dulcolax	Dulcolax	NN	B-NP	O
,	,	,	O	O
clindamycin	clindamycin	NN	B-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
eight	eight	CD	B-NP	O
hours	hour	NNS	I-NP	O
for	for	IN	B-PP	O
another	another	DT	B-NP	O
ten	ten	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
Colace	Colace	NN	B-NP	O
enema	enema	NN	I-NP	O
or	or	CC	O	O
laxative	laxative	JJ	B-NP	O
choice	choice	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
for	for	IN	B-PP	O
constipation	constipation	NN	B-NP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	O
5000	5000	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
lactulose	lactulose	NN	B-NP	O
30	30	CD	B-NP	O
milliliters	milliliter	NNS	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
hold	hold	NN	I-NP	O
for	for	IN	B-PP	O
loose	loose	JJ	B-NP	O
stool	stool	NN	I-NP	O
,	,	,	O	O
Reglan	Reglan	NN	B-NP	O
ten	ten	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-PP	O
q.	q.	NN	B-NP	O
six	six	CD	I-NP	O
for	for	IN	B-PP	O
nausea	nausea	NN	B-NP	O
or	or	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
,	,	,	O	O
oxycodone	oxycodone	NN	B-NP	O
five	five	CD	I-NP	O
to	to	TO	I-NP	O
ten	ten	CD	I-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.	q.	FW	I-NP	O
four	four	CD	I-NP	O
to	to	TO	B-PP	O
six	six	CD	B-NP	O
for	for	IN	B-PP	O
breakthrough	breakthrough	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
Fleets	Fleets	NNP	B-NP	O
Phospho-Soda	Phospho-Soda	NNP	I-NP	O
45	45	CD	B-NP	O
liters	liter	NNS	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
constipation	constipation	NN	B-NP	O
,	,	,	O	O
Senna	Senna	NNP	B-NP	O
tablets	tablet	VBZ	B-VP	O
two	two	CD	B-NP	O
tabs	tab	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Neurontin	Neurontin	NN	B-NP	B-protein
100	100	CD	B-NP	I-protein
milligrams	milligram	NNS	I-NP	I-protein
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Metformin	Metformin	NNP	B-NP	O
500	500	CD	I-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
OxyContin	OxyContin	NN	B-NP	O
ten	ten	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.	q.	NN	I-NP	O
12	12	CD	B-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
Cozaar	Cozaar	NNP	B-NP	O
50	50	CD	I-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
hold	hold	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
95	95	CD	B-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
250	250	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
ten	ten	CD	I-NP	O
days	day	NNS	I-NP	O
and	and	CC	B-NP	O
then	then	RB	I-NP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
four	four	CD	I-NP	O
weeks	week	NNS	I-NP	O
after	after	IN	B-PP	O
that	that	DT	B-NP	O
as	as	IN	B-SBAR	O
described	describe	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
times	time	NNS	I-NP	O
30	30	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Adalat	Adalat	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
nifedipine	nifedipine	NN	I-NP	O
extended	extend	VBD	B-VP	O
release	release	NN	B-NP	O
-RRB-	-RRB-	HYPH	O	O
60	60	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
hold	hold	NN	I-NP	O
for	for	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
95	95	CD	B-NP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
14	14	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
PLAN	PLAN	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
her	her	PRP$	B-NP	O
LFT	LFT	NN	I-NP	O
's	's	POS	B-NP	O
rechecked	rechecke	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
week	week	NN	I-NP	O
to	to	TO	B-VP	O
ensure	ensure	VB	I-VP	O
that	that	IN	B-SBAR	O
they	they	PRP	B-NP	O
are	be	VBP	B-VP	O
normalizing	normalize	VBG	I-VP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
HILTON	HILTON	NNP	B-NP	O
BIRD	BIRD	NNP	I-NP	O
,	,	,	O	O
WI48	WI48	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ROSENDO	ROSENDO	NNP	B-NP	O
FARGNOLI	FARGNOLI	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
JP47	JP47	NNP	I-NP	O
FW558/633899	FW558/633899	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
58556	58556	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

B2KS6O0GAA	B2KS6O0GAA	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
10/10/02	10/10/02	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/10/02	10/10/02	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

CRISTOBAL	CRISTOBAL	NNP	B-NP	O
S.	S.	NNP	I-NP	O
HARWIN	HARWIN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
TK13	TK13	NNP	I-NP	O

